New Boston Scientific Corporation CEO Sees a Turnaround in the Making

Published: Nov 02, 2012

Boston Scientific Corp. (BSX)’s Michael Mahoney, who took the helm yesterday as chief executive officer, says innovation and smooth integration of recent acquisitions will return the company to growth next year.

The Natick, Massachusetts-based maker of heart devices has been on a buying spree. Last quarter, it purchased BridgePoint Medical Inc. for its product to treat totally blocked arteries and Rhythmia Medical Inc., which makes equipment to guide doctors during heart procedures. It’s also branching out with treatments for asthma, minimally invasive heart valve repair and novel defibrillators.

Back to news